Nitric oxide releasing photoresponsive nanohybrids as excellent therapeutic agent for cervical cancer cell lines.

Gold nanoparticles (GNPs) that can release nitric oxide (NO) on visible-light irradiation were prepared using 2-mercapto-5-nitro benzimidazole (MNBI) as stabilizer. These nanoparticles meet overall prerequisites for biomedical applications like small sizes, water solubility, and stability. It was found that even a very low dosage of MNBI-stabilized GNPs exhibit appreciable tumor cell mortality against cervical cancer cell lines, demonstrating the role of NO in killing cancer cells.

[1]  L. Keefer.  Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances , 2011, ACS chemical biology.

[2]  C. Lambert,et al.  Electrochemical and optical characterization of triarylamine functionalized gold nanoparticles. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[3]  G. Navarrete-Vázquez,et al.  Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents , 2011, Archives of pharmacal research.

[4]  Ping I. Lee,et al.  Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. , 2010, Molecular pharmaceutics.

[5]  S. Sortino,et al.  Nitric oxide photocaging platinum nanoparticles with anticancer potential , 2008 .

[6]  M. Schoenfisch,et al.  Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. , 2008, ACS nano.

[7]  M. Blanchard‐Desce,et al.  Quenching of molecular fluorescence on the surface of monolayer-protected gold nanoparticles investigated using place exchange equilibria. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[8]  S. Petralia,et al.  Photodelivery of nitric oxide from water-soluble platinum nanoparticles. , 2007, Journal of the American Chemical Society.

[9]  Mohamed A. Omar,et al.  Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles. , 2006, Bioorganic & medicinal chemistry.

[10]  Freya Q. Schafer,et al.  Nitric oxide as a cellular antioxidant: a little goes a long way. , 2006, Free radical biology & medicine.

[11]  Takayoshi Suzuki,et al.  Photoinduced nitric oxide release from nitrobenzene derivatives. , 2005, Journal of the American Chemical Society.

[12]  K. G. Thomas,et al.  Investigations on Nanoparticle−Chromophore and Interchromophore Interactions in Pyrene-Capped Gold Nanoparticles , 2004 .

[13]  I. Yamazaki,et al.  Metal and size effects on structures and photophysical properties of porphyrin-modified metal nanoclusters , 2003 .

[14]  I. Yalcin,et al.  Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitors. , 2003, Farmaco.

[15]  M. Fox,et al.  Energy transfer from a surface-bound arene to the gold core in ω-fluorenyl-alkane-1-thiolate monolayer-protected gold clusters , 2003 .

[16]  Weiming Xu,et al.  The role of nitric oxide in cancer , 2002, Cell Research.

[17]  Ming Xian,et al.  Nitric oxide donors: chemical activities and biological applications. , 2002, Chemical reviews.

[18]  L. Keefer,et al.  Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives. , 2002, Chemical reviews.

[19]  C. Czuprynski,et al.  Use of Hoechst 33342 Staining To Detect Apoptotic Changes in Bovine Mononuclear Phagocytes Infected with Mycobacterium avium subsp. paratuberculosis , 2001, Clinical Diagnostic Laboratory Immunology.

[20]  L. Ignarro.  Nitric oxide: a unique endogenous signaling molecule in vascular biology. , 1999, Bioscience reports.

[21]  R. Furchgott,et al.  Endothelium-Derived Relaxing Factor: Discovery, Early Studies, and Identifcation as Nitric Oxide (Nobel Lecture). , 1999, Angewandte Chemie.

[22]  F. Murad,et al.  Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling , 1999, Bioscience reports.

[23]  Y. Kato,et al.  Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  I. Nakanishi,et al.  New reagents for controlled release of nitric oxide. Structure-stability relationships , 1996 .

[25]  H. Vinters,et al.  Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes , 1995, Neuroscience.

[26]  E. Culotta,et al.  NO news is good news. , 1992, Science.

[27]  P. Ramwell,et al.  Vascular relaxation mediated by hydroxylamines and oximes: their conversion to nitrites and mechanism of endothelium dependent vascular relaxation. , 1989, Biochemical and biophysical research communications.

[28]  G. Marconi,et al.  New insight on the photoreactivity of the phototoxic anti-cancer flutamide: photochemical pathways selectively locked and unlocked by structural changes upon drug compartmentalization in phospholipid bilayer vesicles , 2001 .

[29]  G. Marconi,et al.  The Photochemistry of Flutamide and its Inclusion Complex with β-Cyclodextrin. Dramatic Effect of the Microenvironment on the Nature and on the Efficiency of the Photodegradation Pathways¶ , 2001, Photochemistry and photobiology.